Generic Name:
difelikefalin
Project Status:
Active
Therapeutic Area:
Chronic kidney disease
Manufacturer:
Otsuka Canada Pharmaceutical Inc.
Brand Name:
Korsuva
Project Line:
Reimbursement Review
Project Number:
SR0752-000
NOC Status at Filing:
Post NOC
Details
Manufacturer Requested Reimbursement Criteria1:
For the treatment of moderate to severe pruritus associated with chronic kidney disease in adult patients on hemodialysis.
Submission Type:
Initial
Fee Schedule:
Schedule A
Indications:
For the treatment of moderate to severe pruritus associated with chronic kidney disease in adult patients on hemodialysis.
- The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of CADTH. Reimbursement criteria from CADTH will be documented in the final recommendation, if applicable.